VACCINE SUPPLEMENT Coming soon! Decade of Vaccines (early 2013) Guest editors: Pedro Alonso Barcelona Institute For Global Health –ISGlobal Ciro de Quadros Sabin Vaccine Institute Altaf A. Lal Barcelona Institute For Global Health –ISGlobal With contributions from over 100 authors www.journals.elsevier.com/vaccine Rethink the way you publish DECADE OF VACCINES SUPPLEMENT Free access to these high quality articles: • Enabling implementation of the Global Vaccine • Accelerating the Development of a Safe and Action Plan: Developing investment cases Effective HIV Vaccine: HIV Vaccine Case to achieve targets for measles and rubella Study for the Decade of Vaccines prevention • Case Study For Vaccine Against Leishmaniasis • The imperative for stronger vaccine supply • Global Support for New Vaccine and logistics systems Implementation in Middle Income Countries • Generating and Sustaining Public Demand and Political Support for Vaccines: A Perspective • Measuring Government Commitment to from Contributors to the Decade of Vaccines Vaccination Collaboration • The need for targeted implementation • Applying an equity lens in the Decade of research to improve coverage of basic Vaccines vaccines and introduction of new vaccines • The estimated mortality impact of vaccinations • Strategic Priorities for RSV Vaccine forecast to be administered during 2011–2020 Development in 73 countries supported by the GAVI • Developing Countries Vaccine Manufacturers Alliance Network: Doing Good by making high quality • Vaccine research, development and innovation vaccines affordable for all in Brazil: a translational science perspective • Desirability and feasibility of a vaccine against • The Human Hookworm Vaccine cytomegalovirus • Delivering the Promise of the Decade of • Effective vaccine safety systems in all Vaccines: Opportunities and Challenges in the countries: a challenge for more equitable Development of High Quality New Vaccines access to immunization • Projections of the Costs, Financing and • Civil Society, the implementing partner to the Additional Resource Requirements for Global Vaccine Action Plan (GVAP) Low and Lower Middle Income Country • Analysis of the Procurement and Pricing Immunization Programs over the Decade, Architecture for Vaccines 2011–2020 • Vaccine development and deployment: • Moving forward with strengthening routine opportunities and challenges in India immunization delivery as part of measles and rubella elimination activities • Group A Streptococcal Vaccines: Paving a Path for Accelerated Development • Strategies to advance vaccine technologies for resource-poor settings • Preventive Vaccines for Tuberculosis • New vaccine introductions: Assessing the • The need and challenges for development of impact and the opportunities for immunization an Epstein-Barr virus vaccine and health systems strengthening • Malaria Vaccine R&D in the Decade of • A Global Regulatory Science Agenda for Vaccines: Breakthroughs, Challenges and Vaccines Opportunities For further information about Decade of Vaccines Collaboration contact [email protected] www.journals.elsevier.com/vaccine Rethink the way you publish.